Sufficient Rights. As of the Effective Date, it owns or Controls its Patents necessary to conduct the Collaboration and to grant the rights and licenses to Ambit, and to fulfill its duties and obligations pursuant to this Agreement. To the knowledge of Cephalon, as of the Effective Date, the practice of the Cephalon IP does not violate the valid patent rights of any Third Party.
Sufficient Rights. Takeda has all rights necessary to grant the rights and licenses under the Takeda Intellectual Property Rights and rights of reference to Regulatory Materials, in each case, Controlled by Takeda as of the Effective Date that it grants to Licensee in this Agreement.
Sufficient Rights. As of the Effective Date, to the best of Ambit’s knowledge after due inquiry, Ambit represents and warrants that Ambit owns or Controls its Patents necessary to conduct the Collaboration and to grant the rights and licenses to Cephalon, and to fulfill its duties and obligations pursuant to this Agreement. As of the Effective Date, to the best of Ambit’s knowledge after due inquiry, Ambit represents and warrants that the Collaboration Compounds described in Section 1.17(i), and Ambit’s activities with respect to the First Collaboration Target as currently conducted and as proposed to be conducted, including the practice of the Ambit IP in connection therewith, do not violate the valid patent rights or other intellectual property rights of any Third Party, and to the best knowledge of Ambit after due inquiry, as of the Effective Date, all other practice of the Ambit IP does not violate the valid patent rights or other intellectual property rights of any Third Party.
Sufficient Rights. RPI owns or possesses adequate licenses or other rights to use all Patents, Patent Rights, Inventions, and Know-How including an exclusive license to the Cech Patents and Ribozyme Technology to conduct research, [ * ] Confidential treatment requested to grant rights and licenses granted herein to LILLY, and to fulfill its other duties and obligations pursuant to this Agreement.
Sufficient Rights. As of the Effective Date, it owns or Controls its Patent Rights, to conduct the Research Collaboration and to grant the rights and licenses to Pharmacopeia, and to fulfill its duties and obligations pursuant to this Agreement. To the knowledge of Organon, as of the Effective Date the rights and licenses granted to Pharmacopeia hereunder do not violate the rights of any Third Party to which Organon has granted a license.
Sufficient Rights. Kayla represents that it has the full and legal rights and authority to license the Licensed IP to Codiak.
Sufficient Rights. (i) the Borrower’s ownership and lease of its properties, the Transaction Documents and the Applicable Permits create rights in the Borrower sufficient to enable it to develop, construct, finance, own and operate the Projects and to perform as required pursuant to and in accordance with the Transaction Documents; and (ii) there are no material services, materials or rights (including utility services and any Real Property Rights) required for the development, construction, finance, operation or routine maintenance of the Projects in accordance with this Agreement and the ESAs, other than those available under the Project Documents or that can reasonably be expected to be commercially available at the site of each Project.
Sufficient Rights. Licensee covenants, represents and warrants that it has all rights to enter into this Agreement and to perform its obligations hereunder.
Sufficient Rights. Except as stated in Exhibit 15.1(h) listing licenses and excluded sequences, pathways, physically contiguous sequences and currently active RPI internal programs as of the Effective Date, it owns or possesses adequate licenses or other rights to use all patents, patent rights, inventions, and know-how including an exclusive license to the Cech Patents and Ribozyme Technology to conduct research, to grant rights and licenses granted herein to Schering, and to fulfill its other duties and obligations pursuant to this Agreement. To the knowledge of RPI, as of the Effective Date the rights and licenses granted to Schering hereunder do not violate the RPI licenses to the Cech Patents and Ribozyme Technology or the rights of any Third Party to which RPI has granted a license. RPI has not, to the best of its knowledge as of the Effective Date, entered into any contract, agreement, or other arrangement with a Third Party inconsistent with this Agreement.
Sufficient Rights. The Retained Intellectual Property together ----------------- with the Licensed Technology comprises all Intellectual Property necessary for Supplier to manufacture and supply Products in accordance with the Specifications in effect as of the Effective Time pursuant to this Agreement. The foregoing representations and warranties shall apply to computer systems and software owned by third parties only to the extent use of those systems or software is specifically required by the Specifications, but shall not apply to other uses of such computer software or systems.
